Graphene 3D Lab Announces R&D-Royalty Agreement with a Fortune 500 Manufacturer

NEW YORK, Dec. 1, 2015, GGG, GPHBF, /CNW/ Graphene 3D Lab Inc. (TSXV: GGG) (OTCQB: GPHBF) ( Graphene 3D ) and Graphene Laboratories Inc. are pleased to announce they have signed a research, development and royalty agreement ( Agreement ) with a Fortune 500 listed manufacturer. Initially, the Agreement encompasses the development of multi-phased deliverables over the course of the next 12 months. For competitive reasons and pursuant to confidentially clauses contained with the Agreement, neither specific research objectives nor the identity of the Agreement partner can be publicly disclosed. Upon successful completion of the research phase, and subject to approval by the U.S. Food & Drug Administration, the developed materials will become a part of a consumer retail product. The Agreement calls for all research and development costs and royalty obligations to be paid by the partner, as well as a first-right-of-refusal for supply of any graphene related materials in future manufacturing
http://bit.ly/1lVylPY

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: